Table 1.
Agonist | Mode | E1obs | E1corr | Kd | ΔG |
µM | kcal/mol | ||||
TMA | H | 0.7 | 2.6 × 10−3 | 25.8 | −6.2 |
L | 0.004 | 1.5 × 10−5 | 4,470 | −3.2 | |
ACh | HHH | 3.7 | 0.09 | 0.74 | −8.3 |
HH | 0.9 | 0.02 | 3.4 | −7.4 | |
H | 0.2 | 5 × 10−3 | 13.4 | −6.6 | |
L | 0.01 | 2.5 × 10−4 | 268 | −4.8 | |
ACha | − | 0.1 | 6.3 × 10−3 | 10.6 | −6.7 |
All AChRs had αP197A and the αε knockout mutation εP121R (70 mV; [TMA] = 5 mM and [ACh] = 10 mM). Mode, H for high PO and L for low PO. E1obs, observed gating equilibrium constant with one agonist at the αδ site; E1corr, gating equilibrium constant after correction for the background mutations; Kd = (E0WT/E1corr), where E0WT = 6.7 × 10−8 at 70 mV (Nayak et al., 2012); ΔG, αδ-binding free energy (+0.59 lnKd). The adult WT, αδ Kd values are: TMA (580 µM; −4.4 kcal/mol) and ACh (175 µM; −5.1 kcal/mol). Additional background mutations (total fold increase in E0): TMA, εL269F + εS450A (271); ACh, βV266A (40), ACha, εL269F (16).
δW57A added to the background (WT value is KdACh = 80 µM; −5.6 kcal/mol (Nayak et al., 2014).